Untitled
- title: 'In Data We Trust—But Not by Default: Why Life Sciences ...' url: https://www.nexustek.com/insights/zero-trust-security-life-sciences
- title: Cloud Security Best Practices for Clinical Laboratories url: https://www.accountablehq.com/post/cloud-security-best-practices-for-clinical-laboratories-a-hipaa-compliant-guide
- title: '[PDF] Zero-Trust Architecture Implementation for Securing Interoperable ...' url: https://glojit.com/index.php/glojit/article/download/9/12
- title: What Is HIPAA-Compliant Authentication and How It Works url: https://www.oloid.com/blog/hipaa-compliant-authentication
- title: Cybersecurity url: https://kpmg.com/kpmg-us/content/dam/kpmg/pdf/2023/building-cyber-resilient-life-sciences-organization.pdf
- title: 'Best Practices for PHI Access Logging: Stay HIPAA ...' url: https://www.accountablehq.com/post/best-practices-for-phi-access-logging-stay-hipaa-compliant-and-audit-ready
- title: Zero Trust Cybersecurity for Health Technology Tools, ... url: https://standards.ieee.org/industry-connections/activities/zero-trust-cybersecurity-for-health-technology-tools-services-and-devices/
- title: '[PDF] zero-trust microservices architecture for ai-driven clinical ... - IRJMETS' url: https://www.irjmets.com/upload_newfiles/irjmets80200097963/paper_file/irjmets80200097963.pdf
- title: Healthcare & Life Sciences Cybersecurity & Compliance url: https://myitmanager.in/industries/healthcare-life-sciences/
- title: 'Identity Platform: HIPAA Implementation Guide' url: https://cloud.google.com/security/compliance/hipaa/identity-platform
- title: Data Integrity in Pharma and Audit Trail Control url: https://complere.tech/compliance/data-integrity-audit-trails/
- title: Securing Email Communication url: https://www.accountablehq.com/post/best-practices-to-secure-computer-stored-lab-results-as-ephi
- title: AmpleLogic Launches AI-Powered User Access Management Software to Close the Last Compliance Gap in Pharma IT url: https://www.openpr.com/news/4564655/amplelogic-launches-ai-powered-user-access-management
- title: Pharma MFA & 21 CFR Part 11 Compliance url: https://www.msbdocs.com/blog/pharmaceutical/multi-factor-authentication-pharma/
- title: Phishing-Resistant MFA & IAM for Pharma - Rainbow Secure url: https://www.rainbowsecure.com/service-post/pharma/ date: '2026-08-21' mood: skeptical scheduled_publish_at: '2026-08-21T12:00:00+03:00' status: published summary: 'A regulated life sciences stack lives or dies on identity. One bad token, one sloppy boundary, one stale privilege in a FHIR gateway can freeze a trial workflow, block a manufacturing release, or make a lab result untrustworthy enough to quarantine it while everyone argues about who touched what.
The part people keep missing is that cyber risk here is operational risk, full stop. Zero trust in life sciences works by treating identity, context, and session state as the control plane, with continuous verification instead of a warm feeling from being inside the network. That matters when a researcher signs into a cloud notebook, a clinician hits a FHIR API, and an instrument service account pushes assay data into a LIMS that nobody wants to redeploy until next quarter.
Picture a Tuesday night in a CRO. The site is quiet, the batch window is open, and a token tied to an integration user has drifted past its intended scope. Maybe it was overpermitted from the start. Maybe it was inherited from a human account that should have been retired months ago. The failure is boring in exactly the way outages always are. A queue backs up, the audit trail starts to look suspicious, the release manager refuses to trust the data, and the team spends the next six hours proving that science was not altered by an account that should never have existed in the first place.
PHI protection sits in the same pile, and this is where the cloud story stops being a keynote slide and becomes an engineering decision. Identity platforms should not become accidental vaults for patient data, and cloud guidance is blunt about that, saying PHI should not be stored in identity attributes or passed through tokens and claims. That leaves a hard job: keep identity systems as identity systems, keep clinical data in the right stores, and make the handoff between them auditable without smuggling sensitive fields into places built to authenticate, not to hold records.
Audit logs are where the argument gets real. Regulators care about attributable, time stamped, tamper evident records, and the useful logs are the ones that can tell you who acted, on what resource, from which system, under which context, and whether the action succeeded. If those logs are brittle, missing, or easy to rewrite, you do not have a compliance framework. You have a forensic delay line.
Labs, trials, and manufacturing all need the same security model, even if the stacks differ. LIMS, ELN, MES, eQMS, FHIR gateways, cloud IAM, service accounts, and API gateways have to fit together as one trust boundary, with least privilege, MFA for privileged access, conditional access, immutable logging, and segmentation that limits blast radius when a credential turns bad. Engineers know the difference between a protected system and a paper shield. The protected system still works at 2 a.m. when a token breaks, a user leaves, or an integration starts behaving like a thief with a valid badge.
That is the point worth naming plainly. The security model has to keep data usable and trusted, because in regulated life sciences unusable data is failed science with paperwork attached. If the boundary is weak, the instrument is not the only thing that stops. The pipeline does too.
If this is the failure mode sitting in your stack, hello@example.com is where the conversation starts.' tags: - technology-trends - cybersecurity - semantic-data title: When the Badge Fails, the Lab Stops type: technology_trends